Resumen
Aggressive, dyscontrolled behavior is a highly impairing complication of numerous psychiatric disorders that affect children and adolescents. In clinical practice, aggressive and other destructive behaviors have long been targets for pharmacotherapy. However, the evidence base to support the multitude of agents and their combinations in widespread use remains limited. This chapter reviews clinical considerations for the pharmacotherapeutic management of aggressive behavior in the context of the “underlying” psychopathology that generates these disturbances. Specific pharmacotherapy treatment approaches to key patient populations are presented, along with their evidence base and practical guidance for their use.
| Idioma original | English (US) |
|---|---|
| Título de la publicación alojada | Pediatric Psychopharmacology Evidence |
| Subtítulo de la publicación alojada | A Clinician’s Guide |
| Editorial | Springer Nature |
| Páginas | 275-304 |
| Número de páginas | 30 |
| ISBN (versión digital) | 9783031574726 |
| ISBN (versión impresa) | 9783031574719 |
| DOI | |
| Estado | Published - ene 1 2024 |
ASJC Scopus subject areas
- General Medicine